Buy, Hold, or Sell: Tech Compression Dragged Abbott Labs Under $91, but 1 Massive Diabetes Catalyst Makes It a Screaming Buy
Yahoo Finance ·
Alex Sirois is a financial writer with experience spanning both retail and institutional investing. He has written for InvestorPlace and held roles at BNY Mellon and Bernstein, giving him a perspective that bridges Main Street portfolios and Wall Street analysis. Alex holds an MBA from George Washington University and has built his career across multiple industries, including e-commerce, education, and translation — a breadth of experience that informs how he breaks down complex financial topics for everyday investors. His writing is conversational, actionable, and grounded in long-term, buy-and-hold investing principles. At 247 Wall St., Alex focuses on delivering analysis that is both accessible and useful, with a clear emphasis on helping readers make more informed decisions with their money.
DYAX Investor Sentiment
Bullish (Long) 68% · Bearish (Short) 32%
422 participants
Related News
- WisdomTree Emerging Markets SmallCap Dividend Fund declares quarterly distribution of $0.8400
- WisdomTree Emerging Markets Multifactor Fund declares quarterly distribution of $0.2250
- Baker Hughes wins subsea systems contract for Eni-BP Angola oil project
- WisdomTree Emerging Markets High Dividend Fund declares quarterly distribution of $0.7250
- WisdomTree Emerging Markets ex-State-Owned Enterprises Fund declares quarterly distribution of $0.2800
- WisdomTree Emerging Markets ex-China Fund declares quarterly distribution of $0.1750